- Home
- YYGH vs IMRX Comparison
YYGH vs IMRX Comparison
Compare YYGH & IMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- YYGH
- IMRX
- Stock Information
- Founded
- YYGH 2010
- IMRX 2008
- Country
- YYGH Singapore
- IMRX United States
- Employees
- YYGH N/A
- IMRX N/A
- Industry
- YYGH
- IMRX Biotechnology: Pharmaceutical Preparations
- Sector
- YYGH
- IMRX Health Care
- Exchange
- YYGH NYSE
- IMRX Nasdaq
- Market Cap
- YYGH 69.2M
- IMRX 62.7M
- IPO Year
- YYGH 2024
- IMRX 2021
- Fundamental
- Price
- YYGH $1.63
- IMRX $1.66
- Analyst Decision
- YYGH
- IMRX Strong Buy
- Analyst Count
- YYGH 0
- IMRX 3
- Target Price
- YYGH N/A
- IMRX $11.00
- AVG Volume (30 Days)
- YYGH 24.6K
- IMRX 200.2K
- Earning Date
- YYGH 04-08-2025
- IMRX 03-20-2025
- Dividend Yield
- YYGH N/A
- IMRX N/A
- EPS Growth
- YYGH 527.44
- IMRX N/A
- EPS
- YYGH 0.04
- IMRX N/A
- Revenue
- YYGH $37,372,731.00
- IMRX N/A
- Revenue This Year
- YYGH N/A
- IMRX N/A
- Revenue Next Year
- YYGH N/A
- IMRX N/A
- P/E Ratio
- YYGH $44.53
- IMRX N/A
- Revenue Growth
- YYGH 55.18
- IMRX N/A
- 52 Week Low
- YYGH $0.72
- IMRX $1.00
- 52 Week High
- YYGH $4.70
- IMRX $3.83
- Technical
- Relative Strength Index (RSI)
- YYGH N/A
- IMRX 49.23
- Support Level
- YYGH N/A
- IMRX $1.52
- Resistance Level
- YYGH N/A
- IMRX $1.91
- Average True Range (ATR)
- YYGH 0.00
- IMRX 0.11
- MACD
- YYGH 0.00
- IMRX 0.03
- Stochastic Oscillator
- YYGH 0.00
- IMRX 51.51
Stock Price Comparison Chart: YYGH vs IMRX
About YYGH YY GROUP HOLDING LIMITED
YY Group Holding Ltd is a data and technology driven company focused on developing enterprise intelligent labor matching services and smart cleaning services founded in Singapore. It provides enterprise manpower outsourcing and smart cleaning services in Singapore and Malaysia. The group has two operating segment, which is cleaning services segment and manpower outsourcing services, Maximum revenue is generated from cleaning services.
About IMRX Immuneering Corporation
Immuneering Corp is a biopharmaceutical company. It is focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying deep knowledge of translational bioinformatics to every stage of the drug development process. The company's proprietary computational Disease Cancelling Technology platform enables Immuneering's drug discovery programs. The company also provides unparalleled computational biology capabilities to pharmaceutical and biotechnology companies.